Mutual funds bet big on healthcare stocks after Trump's tariff pause. Is the danger really over?
Mutual funds with highest exposure in health stocks
Returns snapshot
Outlook
(You can now subscribe to our
(You can now subscribe to our ETMarkets WhatsApp channel
Donald Trump 's 90-day pause on reciprocal tariffs announced on April 9, 2025, brought much-needed stability to stock markets and lifted sentiment in the pharma and healthcare sectors, which had been clouded by uncertainty.The pharmaceutical sector found itself in a unique position, having received exemptions in the initial tariff announcements which kicked-in on April 2, though no clarity on what lay ahead. Between April 2 and April 9, the Nifty Healthcare index had declined by over 3%, or nearly 1,300 points.However, the Nifty Healthcare index staged a strong rebound following the pause, rising 7% or around 2,650 points over the remaining 12 trading sessions of the month. This recovery was accompanied by notable institutional activity, with mutual funds increasing their holdings in 11 healthcare stocks in April compared to March.Healthcare was also among the sectors where MF ownership was higher by over 1% versus the sector's weight in the BSE 200 index.According to a Motilal Oswal report, 17 funds were over-owned and MFs weight on the sector stood at 7.6% in April, behind private banks (18.9%), technology (8.3%) and automobiles (8%). Meanwhile, the healthcare sector in BSE 200 stands at 5.4%, the report revealed.Highest MoM buying of 11.43% in April was seen in midcap stock Syngene International . It was followed by Glenmark Pharmaceuticals Dr. Reddy's Laboratories and Laurus Labs where mutual funds added stake by 7.63%, 6.05% and 3.85%, respectively.Others like Lupin, Aurobindo Pharma, Divi's Laboratories, Sun Pharmaceutical Industries, Abbott India, Ipca Laboratories and Biocon also saw mutual fund action towards the buying side.Nine healthcare stocks also went under the hammer and saw a sell-off. These were Zydus Lifesciences Torrent Pharmaceuticals , Max Healthcare Institute, Mankind Pharma, Granules India, Fortis Healthcare, Cipla, Apollo Hospitals Enterprise and Alkem Laboratories.MF selling was highest in Torrent Pharma and Zydus Lifesciences at 8.34% and 4.87%, respectively. The next in the pecking order were Granules, Apollo and Mankind where MFs sold 3.89%, 3.64% and 3.61%. The others saw a sell-off between 1.67% and 0.46%.Sumit Bhatnagar, Fund Manager Equity at LIC Mutual Fund said that the healthcare sector often remains resilient due to the essential nature of its services and products and innovations and an aging population continue to drive demand. However, the potential impact of Trump's tariffs on the healthcare sector is a valid concern in his view and tariffs could increase costs for healthcare companies which could affect their profitability. "These increased costs might be passed on to consumers or could lead to reduced margins for healthcare companies," he told ETMarkets.DSP and Quant top the list with holdings of 11.5% and 11.1%, respectively and are followed by Axis MF (10.4%), Mirae (9.7%), HDFC MF (9.1%) and Sundaram MF (8.4%).The lowest holdings are for SBI MF (5.1%), MOFSL (5.5%) and UTI MF (6.1%).Nifty Healthcare index's 1-year returns stand at 17%, outperforming Nifty which has returned 12% in the same period.MFs continued to show trust on Syngene in April despite a 6% drop in share price over a 1-year period. Meanwhile, mutual funds sold shares in laggards Zydus Lifesciences and Alkem which have fallen 14% and 2% in the past 12 months.Divi's remains the best performer in the pack with 60% returns and MFs added stakes in April (1.13%) and March (2%). Glenmark and Laurus, which also saw significant MF action, have returned robust 44% and 36% returns.Lupin, Abbott, Sun Pharma and Biocon have also given double-digit returns in the same period while IPCA, Aurobindo and Dr. Reddy's have delivered single-digit returns.Mutual funds booked partial profits in stocks like Fortis Health, Max Health, Granules, Mankind and Torrent Pharma whose 1-year returns stand in the range of 21% and 56%. Apollo Hospitals has yielded 18% returns while Cipla has been an underperformer with just 6% returns.The sector is again in the eye of the storm as Trump has signed an executive order to bring the prices for prescription (Rx) drugs in line with other developed nations. The order institutes the Most-Favoured-Nation (MFN) price model for drugs as a ceiling which means the US will pay for drugs at the same levels as the lowest paid by other countries."The policy initiatives, if implemented fully, may lead to increased compliance/operational cost for foreign manufacturers, including those in India. We expect generic pharma to continue to underperform due to uncertainty," Nuvama Institutional Equities said in a note. It prefers Ajanta Pharma, Torrent Pharma and Divi's Lab.HDFC Securities sees the generic companies unlikely having any impact, though it expects Sun Pharma with its specialty business in the US, to see some impact of MFN price ceiling for a few of its products. JM Financial sees over 20% growth visibility for hospitals and CDMO for the next 4-5 years. Amongst the hospitals, it likes Max Healthcare, Aster DM and Fortis while Piramal Pharma and One Source in CDMO.However, UBS expects healthcare to outperform Nifty over the next 12-month period as the Zurich-based brokerage reiterated its positive stance on Nifty, seeing an 8% upside with a target of 26,000. In a note of caution on generic pharma export names, it expects earnings downgrades starting in 2HFY26.: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
American Eagle traffic plunges after Sweeney ad backlash
Foot traffic at American Eagle stores fell 9 per cent year over year in the week starting August 3, according to Pass_by data shared exclusively with Retail Brew. This drop marked the second week in a row of declining store visits since the brand launched its ' Sydney Sweeney Has Great Jeans' campaign on July 23. As per the report by Retail Brew, in the first full week after the campaign began — the week starting July 27 — store visits were already down 3.9 per cent YoY, Pass_by reported. Before the campaign, American Eagle was seeing positive traffic growth. The week starting July 6 had visits up 5.9 per cent YoY, and the week starting July 13 saw a 4.9 per cent YoY increase, according to the same data. Competitors also see smaller drops in store visits In the August 3–9 period, other youth-focused clothing retailers also saw lower traffic but not as steep as American Eagle's fall. Abercrombie & Fitch was down 3.3%, H&M down 4.9%, Gap down 2.8%, and Urban Outfitters down 2.7 per cent, as per Pass_by data, reported by Retail Brew. ALSO READ: Grow a Garden Cooking Update: Full list of food pets and how to get Gourmet Eggs Debate grows over Sydney Sweeney ad backlash Pass_by report stressed that correlation is not causation, so there's no proof the Sydney Sweeney ad is directly responsible for the traffic drop. Retail Brew asked American Eagle whether their own data showed store visits or sales changing since the campaign launch. The company did not respond. The ad has drawn criticism from some for alleged eugenic undertones and being oversexualised. Supporters such as The New York Post — have pushed back at critics, calling them a 'crazed woke mob.' High-profile political figures backing the campaign include President Donald Trump, Vice President JD Vance, and Senator Ted Cruz , according to the report by Retail Brew. ALSO READ: What is Sepsis — the heart of the problem behind America's hand soap recall, and how dangerous is it? FAQs Q1. Why did American Eagle's store visits drop recently? American Eagle's store visits fell after launching the controversial Sydney Sweeney ad campaign in late July. Q2. What is the controversy around the Sydney Sweeney American Eagle ad? Some people criticise the ad for being oversexualised and having eugenic undertones, while others defend it.
Time of India
2 hours ago
- Time of India
Tariff tangle: Cast shrimp nets right, and India could come up trumps!
Factors Details Shrimp export share to US ~92% of India's seafood exports ~$2.5 billion New US tariff ~50-59 % (up from 6-8%) Impact on margins Narrow profit margins (4-5%) are likely to be wiped out Potential market response Order cancellations, discounting, renegotiations Financial fallout Rs 600 crore burden on in-transit shipments Diversification efforts Pivoting to the EU, China and Gulf countries Support strategies Branding, RPA talks, support tied to export employment Live Events India produces approximately 900,000 to 930,000 tonnes of shrimp annually, with production volumes fluctuating due to factors such as disease outbreaks, unseasonal rains, and feed costs. In FY 2023-24, India's annual shrimp exports were substantial, totalling around $4.88 billion. Frozen shrimp accounted for the largest share of the country's total marine product exports, which stood at $7.38 August 6, 2025, US President Donald Trump announced an additional 25% tariff on goods imported from India. This move was a penalty tied to India's continued purchases of Russian energy and military equipment and set to take effect on August 27, 2025. Earlier on August 1, 2025, Trump had imposed a 25% reciprocal tariff. With the total tariff now at 50%, it is expected to severely impact key export sectors, such as shrimp, making Indian goods less competitive compared to rivals like Ecuador, which enjoys a much lower tariff of 10% on seafood exports to the US. Trade experts and government officials have stated that this steep tariff makes Indian exports to the US unviable and has prompted the Indian government to explore alternative markets and fast-track domestic reforms to support affected constitutes about 92% of India's seafood exports to the US, with a value of around $2.5 billion in FY 2023-24. Export margins in shrimp are typically narrow, ranging from approximately 4% to 5%. An increase in tariffs to over 50% from the previously existing 6-8% significantly squeezes profitability and makes Indian shrimp uncompetitive against rivals like Ecuador. The Seafood Exporters Association of India has issued a warning that 2,000 containers currently in transit may face additional duties, resulting in an estimated burden of Rs 600 crore to be borne by exporters. Major shrimp-exporter states such as Andhra Pradesh, which saw its marine exports to the US in 2024-25 valued at $170 million—nearly all frozen Vannamei shrimp—are especially susceptible to order cancellations, renegotiations, and financial distress across the supply chain. Share prices of listed companies like Avanti Feeds and Waterbase dropped up to 7% following the tariff announcement, reflecting investor concern over lost US market access and a potential collapse in are exploring new export destinations such as China, the European Union (EU), Japan, and West Asia. However, analysts caution that these transitions will take time to compensate for losses in the US market. The Indian government is encouraging exporters to build indigenous branding and consider support schemes tied to employment in marine exports to maintain competitiveness. Plans are underway for a US-India Regional Partnership Agreement (RPA) aimed at aligning trade and sanitary protocols, which could lead to a reduction in rejections and a more streamlined compliance process similar to the existing arrangements with Ecuador. Rather than subsidies, the government is exploring 'innovative' support strategies that align with the World Trade Organisation (WTO) compliance, moving away from subsidies. These strategies may include marketing campaigns, brand-building efforts, and potentially employment-based export support tariffs imposed by Trump, which have risen to about 50-59%, put a severe strain on the Indian shrimp industry, threatening to erode profit margins and competitiveness in its largest overseas market. While short-term shocks appear unavoidable, mitigation through new trade agreements, branding, compliance upgrades, and market diversification may help avert long-term the challenges in the export market, India's domestic shrimp market presents a significant opportunity for growth. Several factors and initiatives are driving this expansion. India's domestic shrimp market is already a major segment, with forecasts indicating it will reach $22.7 billion by 2033 (GII Research, IMARC Group, Research and Markets). This growth is driven by rising incomes and urbanisation. A growing middle class, equipped with greater disposable incomes, is increasingly adding seafood, such as shrimp, to their diets. There is a growing consumer awareness of the nutritional benefits of shrimp, particularly regarding its high protein content. Shrimp is a widely used ingredient in various Indian cuisines, contributing further to its increased government agencies and private players are actively working to promote domestic consumption. State governments are launching rebranding campaigns to increase awareness and consumption of locally produced shrimp. These campaigns are inspired by successful models of institutes like the National Egg Coordination Committee, which made eggs a household staple. The government is providing financial assistance for shrimp farming, processing, and marketing, including concessional finance for entrepreneurs and investors to set up aquaculture facilities and value-added product processing plants. There is a focus on building better cold storage and distribution networks to ensure the availability of fresh shrimp across the country, including in non-coastal areas. The rise of organised retail and e-commerce platforms is facilitating the sale of value-added shrimp products, like frozen, ready-to-eat, and marinated shrimp. This caters to the demand from urban consumers with busy can indeed turn this crisis around and come up trumps if we cast our nets right!!The writers M. Krishnan is former Principal Scientist & Head, ICAR - Central Institute of Fisheries Education, Mumbai; Badri Narayanan Gopalakrishnan is a visiting Senior Fellow, CSEP, New Delhi.
India Today
3 hours ago
- India Today
US tariff impact will be temporary, private sector should step up: Chief economist
Chief Economic Advisor V Anantha Nageswaran on Wednesday said US tariffs-related challenges will dissipate in the next one or two quarters, and urged the private sector to do more as the country navigates through other longer-term attributed the growth slowdown in FY25, which saw a deceleration to 6.5 per cent from FY24's 9.2 per cent, to tight credit conditions and liquidity issues. The right agriculture policies can add 25 per cent to real GDP growth, Nageswaran the US tariffs, the CEA said it is the second and third order impacts, which will flow once sectors like gems and jewellery, shrimps and textiles have taken the first order brunt, that will be "more difficult" to tackle. The government is aware of the situation and conversations with the impacted sectors have already begun, Nageswaran said, adding that one will hear from the policymakers in the coming days and weeks, but people have to be speculation on whether US officials will visit India for trade talks later this month as reported, Nageswaran said the upcoming meet in Alaska between US President Donald Trump and his Russian counterpart Vladmir Putin is likely to influence the to spell out any details on the trade negotiations between India and the US, the academic-turned-advisor said things are very fluid at the world stage right now with relations swinging from cooperation to stalemate, and spelled out his expectation of the impact of a 50 per cent US tariff on Indian exports."I do believe that the current situation will ease out in a quarter or two. I don't think that from a long-term picture, the India impact will be that significant but in the short run, there will be some impact," he said no one can guess the exact reasons why President Donald Trump chose to slap the high tariffs on India, wondering if it's the fallout of Operation Sindoor or something even more the CEA said the focus on tariff-related issues should not blind us to more "important challenges", including the impact of artificial intelligence, reliance on one country for critical minerals, and their processing and strengthening of supply exhorted the private sector to do more "as we navigate these longer-term challenges, promising that public policy will play the facilitator's role"."Private sector also has a lot of thinking to do, given the massive strategic challenges we face in the coming years... the private sector also has to think about the long-term rather than the next quarter, which is what might have led to many of the challenges we are currently beginning to face," he said in the comments aimed at India however, did not elaborate on the subject any that the government has allocated money towards the research purposes, he said it is now for the private sector to up their investments in the Indian youth is staring at both physical and health issues arising from excess screen use, consumption of ultra-processed food, etc, which is leading to anxieties and even suicidal thoughts among people, the CEA said, seeking the private sector's help to tackle the welcomed the capital expenditure put in by the private sector in FY26 and data to be released in February next year will attest to the consumption story is "quite healthy", the CEA said, pointing to the data on UPI usage. Specifically on urban consumption, he rued that there is no proper data source to capture services consumption, and added that drawing from listed companies' earnings may also not be the right measure as consumption is moving to the unlisted overall resource mobilisation in the economy is not showing any slackening, the CEA said, asking all to look at banks credit growth, commercial paper issuances, and IPO fundraising China, Nageswaran said "we also need to understand the security dimension and look at the USD 100 billion trade deficit beyond just the number". As a solution, there is a need to diversify the sources of imports and the CEA stressed that the private sector will have a role to play naming China, he said only one country supplies critical minerals, which are essential for semiconductors, artificial intelligence tech, and added that the supply is "critically unstable"."We cannot go from crude oil import dependence to critical minerals and ladders import dependence. Understand that crude oil (sources) at least is more diversified," he said."Indian policy-makers must choose between accepting permanent strategic dependence on adversaries or committing the resources necessary for genuine support to independence," Nageswaran that AI will cause labour displacement, Nageswaran pitched for caution in AI adoption and added that "we will have to choose the areas in which we allow AI to be deployed and harnessed, and also the speed with which we do so".There is a need to create at least 80 lakh new jobs per annum in the next 10–12 years, he added.(Disclaimer: The views, opinions, recommendations, and suggestions expressed by experts/brokerages in this article are their own and do not reflect the views of the India Today Group. It is advisable to consult a qualified broker or financial advisor before making any actual investment or trading choices.)- EndsMust Watch
